Shares of Exactech, Inc. (NASDAQ:EXAC) have earned an average recommendation of “Hold” from the seven research firms that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and five have given a hold rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $49.00.
Several equities analysts recently weighed in on EXAC shares. ValuEngine cut Exactech from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Robert W. Baird reissued a “hold” rating and set a $49.00 price objective on shares of Exactech in a research report on Thursday, December 7th. Zacks Investment Research raised Exactech from a “sell” rating to a “hold” rating in a research report on Tuesday, December 26th. Finally, BidaskClub cut Exactech from a “hold” rating to a “sell” rating in a research report on Saturday, January 20th.
EXAC stock remained flat at $$49.25 on Friday. The stock had a trading volume of 255,640 shares, compared to its average volume of 182,742. The company has a market cap of $707.53, a P/E ratio of 4,925.00, a P/E/G ratio of 3.66 and a beta of 0.90. Exactech has a one year low of $23.75 and a one year high of $50.95. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.09 and a current ratio of 4.08.
WARNING: “Exactech, Inc. (EXAC) Receives Consensus Recommendation of “Hold” from Analysts” was posted by Ticker Report and is the property of of Ticker Report. If you are accessing this article on another site, it was stolen and republished in violation of US & international copyright legislation. The correct version of this article can be viewed at https://www.tickerreport.com/banking-finance/3297456/exactech-inc-exac-receives-consensus-recommendation-of-hold-from-analysts.html.
Exactech Company Profile
Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.
Receive News & Ratings for Exactech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech and related companies with MarketBeat.com's FREE daily email newsletter.